Discipline | Therapeutics |
---|---|
Language | English |
Edited by | Michael Morse |
Publication details | |
History | 2001-present |
Publisher | |
Frequency | Monthly |
3.974 (2017) | |
Standard abbreviations | |
ISO 4 | Expert Opin. Biol. Ther. |
Indexing | |
ISSN | 1471-2598 (print) 1744-7682 (web) |
LCCN | 2001243388 |
OCLC no. | 48476209 |
Links | |
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974.[1] The journal is also indexed in MEDLINE.
References
[edit]- ^ "Expert Opinion on Biological Therapy". 2017 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2018.
External links
[edit]